Based on these findings, we speculated that miR‐126 potentially regulates the VEGF‐dependent angiogenesis in SSc‐MVECs through targeting SPRED1‐RAF1/Erk1 and PIK3R2‐PI3k/Akt signalling. The gene discussed is MAPK3; the disease is systemic sclerosis.